Company Overview
Yuanbao Inc., together with its subsidiaries, provides insurance brokerage and agency licenses services in the People's Republic of China. The company offers medical, critical illness, accident, property, and pet insurance products. Yuanbao Inc. was incorporated in 2019 and is headquartered in Beijing, the People's Republic of China.
Why Investors Should Care
Generates a return on equity of 47.9%, reflecting efficient use of shareholder capital.
Return on capital employed stands at 38.0%.
Net profit has compounded at 311.6% per year over the last five years.
Revenue has grown at a 72.6% CAGR over the past five years.
Trades at a P/E of 3.2, below the sector median of 34.6.
Maintains a net profit margin of 29.7%.
Recent Developments
- Dec 2025 Revenue of $4.37B (+33.1% YoY); net profit $1.31B.
- Trailing 12 Months Year-on-year growth — revenue +35.6%, earnings +24.4%.
- 5-Year Trend Long-term compounding — revenue CAGR 72.6%, profit CAGR 311.6%.
Growth & Price Performance
Compounded Sales Growth
| 5 Years: | 72.62% |
| 1 Year: | 35.60% |
Compounded Profit Growth
| 5 Years: | 311.59% |
| 1 Year: | 24.40% |
Stock Price Performance
| 1 Year: | -44.17% |
| 6 Months: | -26.76% |
| 3 Months: | -11.76% |
| 1 Month: | -11.11% |
Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.
- Price vs 50-DMABelow
- Price vs 200-DMABelow
- RSI (14)45.40 · Neutral
P/E of 3.20 is below the sector median of 34.58 — relatively cheaper than peers.
Auto-generated from price history and fundamentals; not investment advice.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth Charts
No fundamental data available for this stock.
Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.
PROS
- Strong return on equity of 47.9%.
- Healthy ROCE of 38.0%.
- Excellent profit margin of 29.7%.
- Compounding revenue at 72.6% over 5 years.
- Profit CAGR of 311.6% over 5 years.
- Attractive dividend yield of 9.44%.
CONS
- Trading 51.3% below its 52-week high.
- In a downtrend (50-DMA below 200-DMA).
* The pros and cons are auto-generated from financial metrics.
Valuation
Growth (CAGR)
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Peer comparison
Peer companies in the same sector (Technology).
| # | Name | CMP $ | P/E | Mkt Cap | Div Yld % | ROCE % | ROE % | Rev CAGR 5Y % | Profit CAGR 5Y % |
|---|---|---|---|---|---|---|---|---|---|
| 1 | YB Yuanbao Inc. | 13.44 | 3.20 | $619.32M | 9.44% | 38.01% | 47.88% | 72.62% | 311.59% |
| 2 | NVDA NVIDIA Corporation NDXSPXAI | 200.75 | 30.79 | $4.86T | 0.47% | 74.66% | 114.29% | 24.64% | 32.12% |
| 3 | AAPL Apple Inc. NDXSPX | 308.91 | 37.35 | $4.54T | 0.37% | 68.72% | 141.47% | 1.81% | 3.92% |
| 4 | MSFT Microsoft Corporation NDXSPXAI | 464.72 | 28.15 | $3.45T | 0.95% | 26.90% | 34.01% | 9.48% | 10.85% |
| 5 | TSM Taiwan Semiconductor Manufacturing Company Limited AI | 404.25 | 35.09 | $2.10T | 0.90% | 30.20% | 36.21% | 18.94% | 19.57% |
| 6 | AVGO Broadcom Inc. NDXSPXAI | 389.28 | 64.13 | $1.85T | 0.68% | 16.70% | 37.28% | 24.38% | 26.24% |
| 7 | MU Micron Technology, Inc. NDXSPXAI | 823.03 | 18.60 | $929.52B | 0.05% | 13.69% | 66.64% | 13.68% | 26.02% |
| 8 | AMD Advanced Micro Devices, Inc. NDXSPXAI | 476.15 | 155.10 | $776.41B | 0.00% | 6.33% | 8.06% | 13.64% | 48.64% |
| 9 | ASML ASML Holding N.V. NDXAI | 1,629.00 | 53.66 | $627.85B | 0.51% | 42.97% | 52.24% | 15.55% | 19.55% |
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios
Quarterly Results
Figures in USD.
| Metric | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Revenue | - | 970.06M | 1.07B | 1.16B | 1.18B | 1.32B |
| Cost of Revenue | 127.02M | 44.76M | 40.90M | 45.07M | - | - |
| Gross Profit | 761.73M | 925.30M | 1.03B | 1.11B | - | - |
| Operating Expenses | - | 680.64M | 772.19M | 803.37M | 389.23M | 878.63M |
| Operating Income | - | 289.41M | 297.73M | 354.54M | 394.90M | 437.23M |
| EBITDA | - | 289.41M | 297.73M | 354.54M | 394.90M | 437.23M |
| Interest Expense | - | - | - | - | - | - |
| Pretax Income | - | 301.82M | 315.81M | 378.27M | 412.81M | 457.00M |
| Tax Provision | - | 6.72M | 11.12M | 7.91M | 75.43M | 69.36M |
| Net Income | - | 295.10M | 304.69M | 370.36M | 337.38M | 387.65M |
| Diluted EPS | - | 7.02 | 6.48 | 7.68 | 6.96 | 8.04 |
Profit & Loss (Annual)
Figures in USD.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Revenue | - | 850.25M | 2.05B | 3.28B | 4.37B |
| Cost of Revenue | - | 101.51M | 213.15M | 333.83M | 391.14M |
| Gross Profit | - | 748.74M | 1.83B | 2.95B | 3.98B |
| Operating Expenses | - | 764.90M | 1.66B | 2.09B | 2.65B |
| Operating Income | - | -16.16M | 175.36M | 858.61M | 1.34B |
| EBITDA | - | -6.65M | 191.50M | 873.55M | 1.35B |
| Interest Expense | - | - | - | - | - |
| Pretax Income | - | -2.34M | 205.48M | 891.41M | 1.41B |
| Tax Provision | - | 12.00K | 291.00K | 25.57M | 101.17M |
| Net Income | - | 18.75M | 203.12M | 865.85M | 1.31B |
| Diluted EPS | - | -9.66 | -7.39 | 9.67 | 27.42 |
Balance Sheet (Annual)
Figures in USD.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Total Assets | - | 1.08B | 1.52B | 2.78B | 4.66B |
| Current Assets | - | 990.58M | 1.41B | 2.67B | 4.46B |
| Cash & Equivalents | - | 373.56M | 863.12M | 1.90B | 860.46M |
| Inventory | - | - | - | - | - |
| Receivables | - | 217.40M | 247.09M | 260.96M | 441.41M |
| Total Liabilities | - | 502.47M | 667.08M | 992.55M | 1.31B |
| Current Liabilities | - | 472.48M | 634.15M | 940.81M | 1.14B |
| Long Term Debt | - | - | - | - | - |
| Total Debt | - | 24.23M | 31.02M | 19.16M | 7.92M |
| Total Equity | - | 574.54M | 853.57M | 1.79B | 3.35B |
| Shares Outstanding | - | 270.48M | 270.48M | 270.48M | 276.48M |
Cash Flows (Annual)
Figures in USD.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Operating Cash Flow | - | 87.72M | 441.97M | 1.21B | 1.50B |
| Investing Cash Flow | - | -218.93M | -45.26M | -157.57M | -2.72B |
| Financing Cash Flow | - | 0 | 18.05M | -9.11M | 196.84M |
| Capital Expenditure | - | -2.44M | -4.64M | -3.34M | -19.04M |
| Free Cash Flow | - | 85.28M | 437.33M | 1.20B | 1.48B |
| Net Change in Cash | - | -131.21M | 414.76M | 1.04B | -1.03B |
Ratios (Annual)
Figures in %.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Gross Margin % | - | 88.1% | 89.6% | 89.8% | 91.1% |
| Operating Margin % | - | -1.9% | 8.6% | 26.1% | 30.6% |
| Net Margin % | - | 2.2% | 9.9% | 26.4% | 29.9% |
| ROE % | - | 3.3% | 23.8% | 48.5% | 39.1% |
| ROCE % | - | -2.7% | 19.8% | 46.7% | 38.0% |
Shareholding Pattern
Top Institutional Holders
| # | Holder | % Held | Shares | Value |
|---|---|---|---|---|
| 1 | Susquehanna International Group, LLP | 9.37% | 3.04M | $40.79M |
| 2 | Franchise GP Ltd | 3.75% | 1.21M | $16.32M |
| 3 | Point72 Asset Management, L.P. | 0.36% | 115.50K | $1.55M |
| 4 | Lighthouse Investment Partners, LLC | 0.29% | 92.56K | $1.24M |
| 5 | Franchise Capital Limited | 0.21% | 66.67K | $895.99K |
| 6 | Barclays Plc | 0.18% | 59.46K | $799.20K |
| 7 | Morgan Stanley | 0.13% | 41.70K | $560.42K |
| 8 | JPMORGAN CHASE & CO | 0.07% | 24.04K | $323.04K |
| 9 | UBS Group AG | 0.06% | 20.11K | $270.24K |
| 10 | RAMSEY QUANTITATIVE SYSTEMS | 0.03% | 10.49K | $140.97K |
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for YB
YB — Frequently Asked Questions
What is the current share price of Yuanbao Inc. (YB)?
As of 2026-08-02 19:16 PDT, Yuanbao Inc. (YB) trades at $13.44 on NasdaqGM. Its 52-week range is $11.42 to $27.62.
What is the market capitalisation of YB?
Yuanbao Inc. (YB) has a market capitalisation of $619.32M on NasdaqGM.
What is the P/E ratio of YB?
YB trades at a trailing price-to-earnings (P/E) ratio of 3.20. The industry average P/E is 34.58. Its price-to-book (P/B) ratio is 1.09.
Does YB pay a dividend?
Yuanbao Inc. (YB) currently offers a dividend yield of 9.44%.
What is the return on equity (ROE) of YB?
YB has a return on equity (ROE) of 47.88%. Its return on capital employed (ROCE) is 38.01%.
Is YB a good stock to buy?
This page provides a data-driven analysis of Yuanbao Inc. (YB), including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.